Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by P. Colson.
Clinical Infectious Diseases | 1999
F. Van Loock; Isabelle Thomas; Jan Clement; S. Ghoos; P. Colson
Puumala is the most common hantavirus serotype in Europe and is spread mainly by the red bank vole. Between 1 July 1992 and 31 January 1994, an outbreak of Puumala virus-induced nephropathia epidemica (NE) occurred in the Belgian Ardennes. Serologically confirmed cases (n = 41) were compared with two groups of asymptomatic seronegative controls. Risks identified included sighting of living rodents, exposure to rodent droppings, and trapping rodents during the 4 weeks preceding onset of symptoms. Activities during this 4-week period that presented the greatest risk were woodcutting, reopening of a nonaerated room, and strenuous physical effort. This is the first case-control study on risk factors for NE in Europe. In comparison with the American form of hantavirus pulmonary syndrome, which is spread by deer mice, professional activity appears to be a more important risk factor for acquisition of hantavirus in Europe.
Scandinavian Journal of Infectious Diseases | 1995
Paul H.P. Groeneveld; P. Colson; Kitty M.C. Kwappenberg; Jan Clement
Serum nitrate levels, a measure of nitric oxide (NO) production in vivo, were very high (95 +/- 14 microM) in 13 patients infected with Puumala virus, the European variant of Hantavirus (HTV), as compared to those in healthy subjects (33 +/- 3 microM). Serum nitrate levels showed a high and significant correlation with scores on the Acute Physiological And Chronic Health Evaluation (APACHE II) scale and with serum creatinine, and an inverse correlation with platelet counts. Serial serum measurements of nitrate in 2 severe cases showed very high levels at the onset of arterial hypotension and acute renal failure. We conclude that excessive amounts of NO are produced in patients infected with Puumala virus and that this reactive nitrogen intermediate could play an important role in the pathogenesis of the disease.
Viral Immunology | 2006
Piet Maes; Jan Clement; Paul H.P. Groeneveld; P. Colson; Tom W.J. Huizinga; Marc Van Ranst
Acta Clinica Belgica | 1995
Jan Clement; Paula McKenna; Jan Groen; Albert D. M. E. Osterhaus; P. Colson; T. Vervoort; Guido van der Groen; H.W. Lee
Epidemiology and Infection | 2011
Jan Clement; N. S. Crowcroft; Piet Maes; F. Van Loock; P. Colson; M. Van Ranst
Clinical Nephrology | 2004
Jan Clement; G. van der Groen; Norbert Lameire; P. Colson; M. Van Ranst
The Lancet | 2000
Jan Clement; P. Colson; Marc Van Ranst
The Lancet | 1996
Jan Clement; P. Heyman; P. Colson; P.H.P. Groeneveld
European Journal of Clinical Microbiology & Infectious Diseases | 2016
Jan Clement; P. Colson; Veroniek Saegeman; Katrien Lagrou; M. Van Ranst
Clinical Microbiology and Infection | 2016
Jan Clement; P. Colson; Veroniek Saegeman; Katrien Lagrou; M. Van Ranst